- Prescription Drugs
- Over-the-Counter Drugs
Pharmaceuticals are the drugs used to diagnose, treat, prevent, or cure the various diseases. The increase in the prevalence of infectious diseases such as Malaria (approximately 300,000 deaths occur due to malaria) and diarrhea (according to WHO, approximately 10% deaths occur due to diarrheal disease), expansion of businesses by global market players by acquiring local companies are anticipated to fuel the Nigeria pharmaceuticals market. Moreover, rise in incidence of chronic diseases such as AIDS and cancer, rapid urbanization, and rise in healthcare expenditure are expected to boost the Nigeria pharmaceuticals market over the forecast years. However, lack of R&D activities may hinder the growth of Nigeria pharmaceuticals market over forecast period.
Nigeria Pharmaceuticals Market Key Developments:
- In March 2017, French pharmaceutical firm, Biogaran SAS acquired Swiss Pharma Nig Ltd for expanding its business in Nigeria
Nigeria Pharmaceuticals Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Nigeria Pharmaceuticals Market Segmentation
By Product Type
By Formulation
- Solid
- Liquid
- Semi-Solid
By Therapeutic Area
- Infectious Diseases
- Malaria
- Diarrhea
- AIDS
- Hepatitis
- Tuberculosis
- Other Infectious Diseases
- Cardiovascular Diseases
- Diabetes and Metabolic Disorders
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Biogaran S.A.S (Servier laboratories)
- Fidson Healthcare PLC
- GlaxoSmithKline PLC
- Emzor Pharmaceutical Industries Ltd. (Emzor Chemists Limited)
- May & Baker Nigeria Plc.
- Chemiron International Limited
- Zolon healthcare limited.
- NEROS Pharmaceuticals Ltd.